A recent report demonstrated that adenylosuccinate synthase (Adssl1), which catalyzes the last step of the de novo purine synthesis pathway, promotes cardiomyocyte proliferation and heart regeneration after myocardial infarction [55], indicating that purine nucleotide metabolism may be targeted therapeutically to alleviate heart conditions. This evidence concerns the gene ADSS1 and myocardial infarction.